Search
Add filters:
Use filters to refine the search results.
Results 1-2 of 2 (Search time: 0.001 seconds).
- previous
- 1
- next
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Apr-2021 | Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL | Martin, M.; Zielinski, C.; Ruiz Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo de las Heras, Begoña; Margelí Vila, Mireia; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M. I.; Murillo, L.; Morales, S.; Alba, Emilio; Gal Yam, E.; Guerrero Zotano, A.; Calvo, L.; Haba Rodríguez, J. de la; Ramos, M.; Álvarez López, Isabel; García Palomo, Andrés; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; García Sáenz, José Ángel; Chacón, José Ignacio; Swift, C.; Thallinger, C.; Gil Gil, Miguel |
| 12-Feb-2020 | Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer | Álvarez López, Isabel; Bezares, S.; Dalmau Portulas, E.; García Martínez, E.; García Sáenz, José Ángel; Gil Gil, Miguel; Martínez de Dueñas, E.; Ribelles, N.; Santaballa Bertrán, A. |
Discover
Subject